Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 20/20 | 0.74 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.74 |
| ▸ | F2 | P00734 | 1/20 | 0.74 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.74 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.69 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.69 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.69 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16135669 | 1.00 | F10 (0.74) | F10ABCB11F2ST14CYP1A2 | |
| SCHEMBL28288534 | 0.85 | F10 (0.85) | F10ABCB11F2ST14CYP1A2 | |
| SCHEMBL15203291 | 0.85 | F10 (0.85) | F10ABCB11F2ST14CYP1A2 | |
| Rivaroxaban SCHEMBL77766 | 0.85 | F10 (1.00) | F10ABCB11F2ST14CYP1A2 | |
| Rivaroxaban SCHEMBL7721848 | 0.85 | F10 (1.00) | F10ABCB11F2ST14CYP1A2 | |
| Rivaroxaban SCHEMBL3914 | 0.85 | F10 (1.00) | F10ABCB11F2ST14CYP1A2 | |
| SCHEMBL7091435 | 0.85 | F10 (1.00) | F10ABCB11F2ST14CYP1A2 | |
| Rivaroxaban SCHEMBL14796329 | 0.84 | F10 (0.98) | F10ABCB11F2ST14CYP1A2 | |
| SCHEMBL1160965 | 0.84 | F10 (0.76) | F10ABCB11F2ST14CYP1A2 | |
| SCHEMBL18897606 | 0.84 | F10 (0.76) | F10ABCB11F2ST14CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9663505-B2 | Process for the preparation of rivaroxaban | GLENMARK PHARMACEUTICALS LIMITED (IN) | 2017-05-30 | — | — | US | disclosed |